Navigation Links
Colgate-Palmolive Announces Collaboration With American Diabetes Association to Educate Americans About the Association Between Oral Health and Diabetes
Date:4/14/2008

NEW YORK, April 14 /PRNewswire-FirstCall/ -- Colgate-Palmolive Company has announced a multi-year educational collaboration with the American Diabetes Association (ADA). This initiative demonstrates Colgate's commitment to improving oral health among Americans, including Americans with diabetes -- a population at increased risk for oral health problems. Colgate-Palmolive, maker of Colgate Total(R) toothpaste, has become a National Strategic Partner of the American Diabetes Association, supporting the development of the organization's new Oral Care activities.

There is an increased prevalence of gum disease among diabetics, leading some researchers to call serious gum disease, also known as periodontitis the "sixth complication of diabetes," adding it to the list of other complications associated with diabetes, such as heart disease, stroke and kidney disease. Emerging research has suggested that the relationship is two-way; not only are people with diabetes more susceptible to periodontal disease, but the presence of gum disease may have the potential to affect blood glucose control and contribute to the progression of diabetes.

"Colgate has long been on the forefront of educating dental professionals about the association between oral health problems and diabetes," said Dr. Foti Panagakos, Director of Professional Relations, Colgate-Palmolive. "We are proud to collaborate with the American Diabetes Association as they launch their new oral care activities, which will help educate medical professionals and diabetes patients about the association between oral health and diabetes, and the practical steps to help improve both oral and possibly overall health."

As a National Strategic Partner to the American Diabetes Association, Colgate will support elements of the American Diabetes Association's new oral care initiatives. Practical and focused information on oral health management for people with diabetes and their physicians will be featured in a new oral care section of the American Diabetes Association's web site. Content will include research updates on the oral health-systemic health association, physician education on oral health as it relates to diabetes, and interactive patient education features, including:
-- "Ask the Dentist" - An on-line web chat series will provide useful oral

care-related tips for people with diabetes. Healthcare providers will

help answer the 25 most frequently asked diabetes care -- oral care

related questions.

-- "Interactive Oral Hygiene"

-- Oral Health Quiz - Consumers can test their "Oral Health IQ" with

this informative, innovative feature.

-- Patient Education Materials - Educational materials available for

download by professionals.

"Colgate's commitment to support ADA's new oral care activities is very important to our mission and the fight against diabetes," said John Buse, MD, PhD, President, Medicine & Science, American Diabetes Association. "As the connection between oral hygiene and diabetes becomes more evident, we need to educate not only people living with diabetes, but the general public as well. This collaboration will enable us to extend our reach to a much larger audience through a variety of vital programs."

To further advance physician education, the American Diabetes Association and the American Dental Association will conduct a joint symposium, supported by Colgate through an unrestricted educational grant, for healthcare professionals focused on diabetes and periodontal disease at the 2008 American Diabetes Association Scientific Sessions.

People with diabetes are generally more susceptible to bacterial infection and have a decreased ability to fight bacteria that invade the gums. It has been reported that the infectious and chronic inflammatory nature of periodontitis can potentially increase insulin resistance and lead to unbalanced blood sugar levels. It is estimated that almost one-third of people with diabetes have severe periodontal disease.

"There are steps that people with diabetes, and people at risk for diabetes, should take to help reduce inflammation of their gums and maintain good oral care," said Maria Ryan, DDS, PhD, professor, SUNY Stony Brook. "I recommend visiting a dental professional regularly, flossing daily, and brushing twice a day for two minutes with an anti-bacterial toothpaste like Colgate Total which is formulated to work for 12 hours against oral bacteria, a major cause of gum inflammation."

About Colgate Total

Colgate Total's patented formula is clinically proven to fight the germs that cause the gum disease gingivitis. Colgate Total has an ingredient with both antibacterial and anti-inflammatory action, delivered in a patented copolymer, which can help prevent gingivitis, an early stage of gum disease which if left untreated, can lead to a more severe form, periodontitis. According to emerging research, periodontitis may be associated with systemic disease. Colgate Total is the only toothpaste both approved by the FDA and accepted by the American Dental Association, to prevent gingivitis. Colgate Total is also one of few brands in America that provides antibacterial benefits and has also been granted the American Dental Association's Seal of Acceptance for Plaque and Gingivitis. Using Colgate Total can promote better oral health and better oral health may help improve overall health. Colgate Total is approved for the prevention of gingivitis, not approved for the prevention or treatment of periodontitis or other diseases.

About Colgate-Palmolive

Colgate-Palmolive is a leading global consumer products company, tightly focused on Oral Care, Personal Care, Home Care and Pet Nutrition. Colgate sells its products in over 200 countries and territories around the world under such internationally recognized brand names as Colgate, Palmolive, Mennen, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, Elmex, Tom's of Maine, Ajax, Axion, Soupline, and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. For more information about Colgate's global business, visit the Company's web site at http://www.colgate.com.

About The American Diabetes Association

The American Diabetes Association is the nation's premier voluntary health organization supporting diabetes research, information and advocacy. The Association's mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. Founded in 1940, the Association provides services to hundreds of communities across the country. For more information, please call the American Diabetes Association at 1-800-DIABETES (1-800-342- 2383) or visit http://www.diabetes.org. Information from both these sources is available in English and Spanish.

CONTACT: Doris Li

For Colgate-Palmolive

(212)798-9814

Doris_Li@nyc.cohnwolfe.com


'/>"/>
SOURCE Colgate-Palmolive Company
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. American Diabetes Association Announces Multi-Year Collaboration With Colgate-Palmolive
2. Hairsprays Nikki Blonsky Joins Colgate-Palmolive and San Francisco Elementary School Students for Bright Smiles Comedy Showcase
3. "High School Musicals" Corbin Bleu Joins Colgate-Palmolive, United Way and Miami-Dade Elementary School Students for Dental Health Challenge
4. Colgate-Palmolive Partners With the National Breast Cancer Foundation to Provide Education and Free Mammograms
5. TOFUTTI Announces 2007 Results
6. Pharmacyclics Announces Conference Call to Discuss Third Quarter 2008 Financial Results
7. Cogdell Spencer Inc. Announces First Quarter Earnings Release and Conference Call Notice
8. CCA Industries, Inc. Announces First Quarter Results
9. Weight Watchers Announces First Quarter 2008 Earnings Conference Call
10. PharmMD Announces Denise Kehoe as Vice President of Business Development
11. Allegro Diagnostics Announces Publication in Cancer Prevention Research of Prediction Model for Lung Cancer Diagnosis Integrating Clinical and Genomic Features
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... miniature, folded, pharmaceutical inserts and outserts. As a means of expanding capabilities ... addition will enable Flottman to individually code professional inserts (PIs) and patient package ...
(Date:12/9/2016)... NY (PRWEB) , ... December 09, 2016 , ... ... and Drug Dependence, Inc. (NCADD) is recommending the film Whispering Spirits ... and the District of Columbia as an education tool in the war against teen ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, Va., wanted ... all types of amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves ... use and could be set up in a matter of minutes, or even seconds. ...
(Date:12/9/2016)... ... 09, 2016 , ... The Holy Name Medical Center Foundation ... on December 3rd, to benefit Holy Name Medical Center's programs and services. More ... over $1 million - the largest event in the Center's history, both in ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying to get ... thought that if the nebulizer had a more child-friendly design, then children would be ... developed the patent-pending NEBY to avoid the need to deliver medication via a nebulizer ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... -- Australia Glaucoma Surgery Devices Market Outlook to ... Glaucoma Surgery Devices Market Outlook to 2022", provides ... Devices market. The report provides value, in millions ... prices (USD) within market segement - Glaucoma Drainage ... and distribution shares data for each of these ...
(Date:12/8/2016)... 2016 KEY FINDINGS The global ... 2017-2023. Various reasons for growth of the medical lifting ... of chronic diseases, high recovery cost of injuries and ... Medical lifting sling refers to an assistive device that ... slings connect to the lift and hold the patient. ...
(Date:12/8/2016)... Lilly and Company (NYSE: LLY ) today ... at the 9 th Clinical Trials on Alzheimer,s ... meet the primary endpoint in the EXPEDITION3 clinical trial, ... dementia due to Alzheimer,s disease (AD), and Lilly will ... of mild dementia due to AD. ...
Breaking Medicine Technology: